Malaria

Malaria is a mosquito-borne disease caused by a parasite called Plasmodium - when infected mosquitoes bite the human body, the parasites multiply in the liver, and then infect red blood cells. Even though this potentially fatal disease can be prevented and cured, each year 350-500 million cases of malaria still occur worldwide, and over one million people die, most of them young children in Africa south of the Sahara, where one in every five (20%) childhood deaths is due to the effects of the disease.

Malaria is so common in Africa because a lack of resources and political instability have prevented the building of solid malaria control programs. Experts say an African child has on average between 1.6 and 5.4 episodes of malaria fever each year and according to the World Health Organization (WHO) as many as half of the world's population are at risk of malaria mainly in the world's poorest and most vulnerable countries and every 30 seconds a child dies from malaria.
What is Malaria?

Malaria is an infectious disease of tropical countries. It is spread by mosquitoes. It is manifested by fever along with chills and rigors. Unless it is diagnosed and treated promptly, it can be fatal. A single mosquito bite may be enough to cause the infection.

Read More

Overview

Feature Articles

Latest Malaria News and Research

New approach could illuminate a critical stage in the life cycle of P. vivax malaria parasite

New approach could illuminate a critical stage in the life cycle of P. vivax malaria parasite

WHO endorses Truenat molecular diagnostic tests for TB

WHO endorses Truenat molecular diagnostic tests for TB

Controlled human infection models as a strategy to accelerate SARS-CoV-2 vaccine development

Controlled human infection models as a strategy to accelerate SARS-CoV-2 vaccine development

Researchers identify mosquito species that could transmit malaria

Researchers identify mosquito species that could transmit malaria

Ghana's efforts to eliminate malaria at risk as economy improves

Ghana's efforts to eliminate malaria at risk as economy improves

Research uncovers malaria's secret to surviving in the blood

Research uncovers malaria's secret to surviving in the blood

Study finds more effective treatment for children with sickle cell anemia

Study finds more effective treatment for children with sickle cell anemia

Tomocube holotomography microscopy reveals novel cholesterol membrane transport system in erythrocytes infected with fatal malaria parasite

Tomocube holotomography microscopy reveals novel cholesterol membrane transport system in erythrocytes infected with fatal malaria parasite

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

Researchers caution use of chloroquine therapy for patients at higher risk of heart rhythm abnormalities

Researchers caution use of chloroquine therapy for patients at higher risk of heart rhythm abnormalities

Impact Biomedical's COVID-19 research published in peer-reviewed scientific journal

Impact Biomedical's COVID-19 research published in peer-reviewed scientific journal

New discovery could open door to next generation malaria vaccine

New discovery could open door to next generation malaria vaccine

Researchers analyze immune properties of ancient human DNA

Researchers analyze immune properties of ancient human DNA

Hydroxychloroquine ineffective in animal SARS-CoV-2 infection

Hydroxychloroquine ineffective in animal SARS-CoV-2 infection

Study: Parasite infection closely linked to the make-up of gastrointestinal microbiome

Study: Parasite infection closely linked to the make-up of gastrointestinal microbiome

Public health officials face wave of threats, pressure amid coronavirus response

Public health officials face wave of threats, pressure amid coronavirus response

Study initiates hydroxychloroquine clinical trial to prevent COVID-19 in healthy people

Study initiates hydroxychloroquine clinical trial to prevent COVID-19 in healthy people

UCD spin-out awarded €4.5 million funding to help combat coronavirus pandemic

UCD spin-out awarded €4.5 million funding to help combat coronavirus pandemic

A lead compound can significantly reduce or eliminate toxoplasmosis and malaria

A lead compound can significantly reduce or eliminate toxoplasmosis and malaria

Baboon could prove to be a relevant model to test Alzheimer's disease interventions

Baboon could prove to be a relevant model to test Alzheimer's disease interventions